P/E ratio for Endo International (ENDPQ)
P/E ratio as of April 2024 (TTM): -0.0001
According to Endo International 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.000149254. At the end of 2022 the company had a P/E ratio of -0.0056.
P/E ratio history for Endo International from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.0056 | -99.61% |
| 2021 | -1.43 | -116.13% |
| 2020 | 8.86 | -451.54% |
| 2019 | -2.52 | 58.89% |
| 2018 | -1.59 | 86.75% |
| 2017 | -0.8498 | -22.5% |
| 2016 | -1.10 | -87.51% |
| 2015 | -8.78 | -35.97% |
| 2014 | -13.7 | 20.47% |
| 2013 | -11.4 | 177.74% |
| 2012 | -4.10 | -119.07% |
| 2011 | 21.5 | 34.11% |
| 2010 | 16.0 | 77.42% |
| 2009 | 9.03 | -28.1% |
| 2008 | 12.6 | -19.92% |
| 2007 | 15.7 | -41.41% |
| 2006 | 26.8 | 34.5% |
| 2005 | 19.9 | 2.33% |
| 2004 | 19.5 | -47.75% |
| 2003 | 37.2 | 45.24% |
| 2002 | 25.6 | -187.86% |
| 2001 | -29.2 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Zogenix ZGNX | -6.56 | 4,391,929.69% | 🇺🇸 USA |
 Cara Therapeutics
CARA | -0.3350 | 224,316.77% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.